Navigation Links
The Ensign Group, Inc. Declares Quarterly Dividend of $0.04 Per Share
Date:12/26/2007

MISSION VIEJO, Calif., Dec. 26 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, today announced that its Board of Directors has declared a quarterly cash dividend of $0.04 per share of Ensign common stock, payable on or before January 31, 2008 to shareholders of record as of December 31, 2007. Ensign paid annual cash dividends in 2002 and 2003, and has paid quarterly cash dividends since the first quarter of 2004.

About The Ensign Group, Inc.

The Ensign Group, Inc.'s operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services for both long-term residents and short-stay rehabilitation patients, at 61 separate operating locations in California, Arizona, Texas, Washington, Utah and Idaho. More information about Ensign is available at http://www.ensigngroup.net.


'/>"/>
SOURCE The Ensign Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
2. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
3. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
4. Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
5. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
6. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
7. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
8. Lilly Declares Fourth-Quarter Dividend
9. Beckman Coulter Declares Quarterly Dividend
10. Wyeth Declares Preferred Stock Dividend
11. Abbott Declares 336th Consecutive Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 GOJO, inventors ... its commitment to antibiotic stewardship at the White House ... and animal health organizations and stakeholders at the White ... years to slow the emergence of antibiotic-resistant bacteria, detect ... and prevent the spread of resistant infections. ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 German-based ... official United States distributor for the Moenninghoff product ... stated, “I am pleased to announce that the R.M. ... market. For our firm, founded in 1916, this is ... R.M. Hoffman is the kind of professional distributor we ...
(Date:6/1/2015)...  Turing Pharmaceuticals AG announced that life sciences executive ... MSc,  has joined the company as president of ... holds a medical degree as well as a ... accomplishments in the pharmaceutical industry, and extensive clinical ... played a leadership role in numerous programs for ...
(Date:6/1/2015)... CHICAGO and RARITAN, N.J. ... & Development, LLC (Janssen) announced data from the ... significant improvement in progression-free survival (PFS) with trabectedin ... with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously ... additional chemotherapy regimen. SAR3007 is the largest randomized ...
Breaking Biology Technology:GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6
... Simple Steps Can Make a Big Difference in Managing ... As this year,s spring nasal allergy season quickly ... to manage their symptoms and ward-off allergens before they ... nasal allergy sufferers prepare for the spring nasal allergy ...
... 2 Epistem Plc,(LSE:EHP) the UK biotechnology and ... a research and development collaboration with Novartis,to identify ... of disease,areas. , The ... programme, with Novartis,s insights into disease pathways &,bioinformatics. ...
... 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... branded generic,pharmaceuticals and innovative anti-cancer pharmaceuticals in the ... to release its 2008,fourth quarter and full year ... opens in the United States. Simcere,s chief executive ...
Cached Biology Technology:Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 2Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 3Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 4Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 5Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 6Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company 2Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009 2
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... University provides molecular-level insights into how cellulose the ... structural component of plant cell walls breaks down ... into any number of useful products, including liquid transportation ... Using a supercomputer that can perform functions thousands of ...
... Ridge, Ill. (December 14, 2012) It is estimated ... prevalent condition known as metabolic syndrome which is a ... factors: large waistline, high triglycerides, low HDL cholesterol, high ... a variety of risk factors that increase the likelihood ...
... 13, 2012 Swift Charities, the charitable arm of ... Fund for Diabetes Research at the Translational Genomics Research ... The Waylon Fund was Swift,s "charity of choice." ... as well as matching contributions from Phoenix-based Swift, were ...
Cached Biology News:Study fuels insight into conversion of wood to bio-oil 2Use 'em, don't lose 'em! Eating egg yolks adds nutritious benefits 2Use 'em, don't lose 'em! Eating egg yolks adds nutritious benefits 3Swift Transportation donates more than $15,000 to the Waylon Fund 2
... Express Cloning Checker Kits provide two highly ... transformation without time-consuming plasmid preparation. By using ... all you need to do is to ... directly from the transformation plates into the ...
Recombinant Equine IL-4, CF...
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
delta-like 1 homolog (Drosophila)...
Biology Products: